Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
EUR 1 - 1
Notice Type:
Contract Notice
Published Date:
01 December 2016
Closing Date:
09 January 2017
Location(s):
FR FRANCE
FR9 DÉPARTEMENTS D'OUTRE-MER (FR FRANCE)
Description:

Fourniture de Médicaments: Hormones systémiques et sexuelles, Muscles et squelette, Système génito-urinaire, Antidotes, Médicaments pour diagnostic, au groupement de commande des CHU et principaux CH.


Lot 1 à 8

Lot no1: betamethasone injectable- sl no1: 4 MG- qté est. 1ère période: 216503/

lot no2: betamethasone orale- sl no1: 2 mg cp- qté est. 1ère période: 21378/

lot no3: betamethasone orale gouttes buvables- sl no1: FLACON- qté est. 1ère période: 13643/

lot no4: betamethasone retard injectable- sl no1: 5.7 MG- qté est. 1ère période: 77830/

lot no5: betamethasone suspension injectable- sl no1: 7 MG- qté est. 1ère période: 16428/

lot no6: calcitonine injectable- sl no1: faible dosage- qté est. 1ère période: 15853/

lot no6: calcitonine injectable- sl no2: fort dosage- qté est. 1ère période: 16097/

lot no7: carbetocine injectable- sl no1: 100 MCG- qté est. 1ère période: 17226/

lot no8: carbimazole orale- sl no1: 5 mg cp- qté est. 1ère période: 316385/

lot no8: carbimazole orale- sl no2: 20 mg cp- qté est. 1ère période: 142009/.


Lot 50 à 54

Lot no50: DINOPROSTONE gel- sL no1: gel intracervical 2.5ml seringue préremplie- qté est. 1ère période: 637/

lot no50: DINOPROSTONE gel- sL no2: gel vaginal 1mg seringue préremplie- qté est. 1ère période: 2954/

lot no50: DINOPROSTONE gel- sL no3: gel vaginal 2mg seringue préremplie- qté est. 1ère période: 10633/

lot no52: DINOPROSTONE syst vaginal- sL no1: système de diffusion vaginal 10mg- qté est. 1ère période: 41398/

lot no53: Dispositif intra-utérin au cuivre- sL no1: Taille Short, surf. De cuivre = 380mm2, eff 5 ans- qté est. 1ère période: 241/

lot no53: Dispositif intra-utérin au cuivre- sL no2: Taille Stand, surf. De cuivre = 380mm2, eff 5 ans- qté est. 1ère période: 241/

lot no54: Dispositif intra-utérin au lévonorgestrel- sL no1: DIU 52mg- qté est. 1ère période: 526/.


Lot 55 à 58

Lot no55: Dispositif intra-utérin Cuivre/Argent- sL no1: Cavité utérine < 7 cm — qté est. 1ère période: 181/

lot no55: Dispositif intra-utérin Cuivre/Argent- sL no2: Cavité utérine > ou égale à 7 cm- qté est. 1ère période: 138/

lot no56: Dispositif intra-utérin pour nullipares- sL no1: DIU nullipares- qté est. 1ère période: 258/

lot no57: dydrogesterone- sl no1: 10 mg Comprimés- qté est. 1ère période: 12035/

lot no58: estradiol- sl no1: 1 mg Comprimés- qté est. 1ère période: 427/

lot no58: estradiol- sl no2: 2 mg Comprimés- qté est. 1ère période: 358/.


Lot 59 à 63

Lot no59: estradiol / cyproterone- sl no1: 2 mg / mg Comprimés- qté est. 1ère période: 63/

lot no60: estradiol / dienogest- sl no1: 2 mg / 2 mg Comprimés- qté est. 1ère période: 12586/

lot no61: estradiol / dydrogesterone- sl no1: 1 mg / 5 mg Comprimés- qté est. 1ère période: 28/

lot no61: estradiol / dydrogesterone- sl no2: 1 mg / 10 mg Comprimés- qté est. 1ère période: 27/

lot no61: estradiol / dydrogesterone- sl no3: 2 mg / 10 mg Comprimés- qté est. 1ère période: 102/

lot no62: estradiol / medroxyprogesterone- sl no1: 1 mg / 2.5 mg Comprimés- qté est. 1ère période: 45/

lot no62: estradiol / medroxyprogesterone- sl no2: 1 mg / 5 mg Comprimés- qté est. 1ère période: 44/

lot no62: estradiol / medroxyprogesterone- sl no3: 2 mg / 5 mg Comprimés- qté est. 1ère période: 44/

lot no63: estradiol / norethisterone 1 mg / 0.5 mg- sL no1: 1 mg / 0.5 mg Comprimés- qté est. 1ère période: 45/.


Lot 64 à 69

Lot no64: estradiol / norethisterone 1 mg / 1 mg- sL no1: 1 mg / 1 mg Comprimés- qté est. 1ère période: 45/

lot no65: estradiol / norethisterone 2 mg / 1 mg- sL no1: 2 mg / 1 mg Comprimés- qté est. 1ère période: 45/

lot no66: estriol / progesterone- sl no1: 0.2 mg / 2 mg Gélule vaginale- qté est. 1ère période: 525/

lot no67: ESTRIOL Comprimés- sL no1: comp 1mg- qté est. 1ère période: 406/

lot no68: ESTRIOL Crème- sL no1: 0.1 % Crème- qté est. 1ère période: 510/

lot no69: ESTRIOL Ovule- sL no1: 0.5 mg Ovule- qté est. 1ère période: 10184/.


Lot 70 à 74

Lot no70: etonogestrel + ethinyl estradiol anneau vaginal- sl no1: Anneau vaginal- qté est. 1ère période: 1063/

lot no71: etonogestrel implant- sl no1: Implant sous cutané 68mg- qté est. 1ère période: 5126/

lot no72: GEMEPROST Ovule- sL no1: 1mg- qté est. 1ère période: 3455/

lot no73: HYDROXYPROGESTERONE injectable- sL no1: amp IM 500mg/2ml- qté est. 1ère période: 2770/

lot no74: IMIDAZOLE ovule ou capsule gynéco. En administration unique- sL no1: Econazole-Tioconazole- qté est. 1ère période: 40440/.


Lot 75 à 80

Lot no75: isoconazole- sl no1: Ovule vaginal- qté est. 1ère période: 175/

lot no76: levonorgestrel- sl no1: comp 0,03mg- qté est. 1ère période: 2284/

lot no77: levonorgestrel / estradiol Dispositif td- sl no1: 0.05 mg / 0.007 mg / 24 h Dispositif transdermique- qté est. 1ère période: 14/

lot no77: levonorgestrel / estradiol Dispositif td- sl no2: 0.05 mg / 0.01 mg / 24 h Dispositif transdermique- qté est. 1ère période: 8/

lot no78: levonorgestrel + ethinylestradiol en association fixe- sL no1: 30 mcg compr- qté est. 1ère période: 114232/

lot no79: levonorgestrel + ethinylestradiol en association fixe pour administration continue- sL no1: 20mcg comp- qté est. 1ère période: 490867/

lot no80: levonorgestrel + ethinylestradiol en association fixe pour administration séquentielle- sL no1: 20 mcg ethinylestradiol cp- qté est. 1ère période: 74810/.


Lot 82 à 90

Lot no82: levonorgestrel + ethinylestradiol pour administration séquentielle triphasique- sL no1: comp- qté est. 1ère période: 31355/

lot no83: LEVONORGESTREL contraception d'urgence post rapport 48h- sL no1: 1.5 mg cp- qté est. 1ère période: 5863/

lot no84: LISURIDE Oral- sL no1: 0.2 mg- qté est. 1ère période: 18110/

lot no85: MEDROGESTONE Oral- sL no1: 5 mg Comprimés- qté est. 1ère période: 36/

lot no86: METHYLERGOMETRINE Injectable- sL no1: 0.2 mg / ml Solution Inject 1 ml- qté est. 1ère période: 4904/

lot no87: metronidazole / nystatine / neomycine- sl no1: Comprimé vaginal- qté est. 1ère période: 7777/

lot no88: METRONIDAZOLE ovule gynécologique- sL no1: ovule gynécologique 500 mg- qté est. 1ère période: 16087/

lot no89: MICONAZOLE capsule gynécologique- sL no1: capsule vaginale 400mg- qté est. 1ère période: 631/

lot no90: MIFEPRISTONE forme orale sèche indication ivg- sl no1: 200 mg Forme Orale- qté est. 1ère période: 131277/.


Lot 91 à 97

Lot no91: MISOPROSTOL Forme orale sèche Indication ivg- sl no1: Forme Orale- qté est. 1ère période: 65069/

lot no92: NOMEGESTROL 3.75 mg- sL no1: 3.75 mg- qté est. 1ère période: 145/

lot no93: NOMEGESTROL 5 mg- sL no1: 5 mg- qté est. 1ère période: 50990/

lot no94: norelgestromine + ethinylestradiol dispositif transdermique- sL no1: dispositif trandermique- qté est. 1ère période: 3418/

lot no95: noresthisterone / ethinylestradiol- sl no1: 0.5 mg / 0.035 mg Comprimés- qté est. 1ère période: 128/

lot no96: promestriene- sl no1: Capsule vaginale 10 mg- qté est. 1ère période: 9568/

lot no96: promestriene- sl no2: Crème vaginale 1 %- qté est. 1ère période: 487/

lot no97: OESTROGENES par voie vaginale- sL no1: Ovule ou Capsule- qté est. 1ère période: 542/

lot no97: OESTROGENES par voie vaginale- sL no2: Crème gynécologique- qté est. 1ère période: 52/.


Lot 98 à 102

Lot no98: QUINAGOLIDE forme orale sèche- sL no1: 150mcg- qté est. 1ère période: 1405/

lot no98: QUINAGOLIDE forme orale sèche- sL no2: 25 et 50 mcg- qté est. 1ère période: 331/

lot no98: QUINAGOLIDE forme orale sèche- sL no3: 75mcg- qté est. 1ère période: 6281/

lot no99: sulprostone- sl no1: 0,5mg injectable- qté est. 1ère période: 17576/

lot no100: ulipristal- sl no1: 5 mg Comprimés- qté est. 1ère période: 57/

lot no101: ulipristal acetate contraception d'urgence post rapport 5 jours- sL no1: 30mg cp- qté est. 1ère période: 2445/

lot no102: uro alfuzosine forme orale sèche- sL no1: 2.5 mg — qté est. 1ère période: 516043/

lot no102: uro alfuzosine forme orale sèche- sL no2: 10 mg LP- qté est. 1ère période: 1534428/.


Lot 103 à 108

Lot no103: uro alprostadil injectable par voie intra-caverneuse- sL no1: 10mcg injectable voie intra-caverneuse- qté est. 1ère période: 1719/

lot no103: uro alprostadil injectable par voie intra-caverneuse- sL no2: 20mcg injectable voie intra-caverneuse- qté est. 1ère période: 700/

lot no104: URO Antispasmodique urinaire de type anticholinergique hors Oxybutinine forme orale sèche- sL no1: Forme orale sèche- qté est. 1ère période: 186513/

lot no105: URO inhibiteur de la 5 alpha réductase- sL no1: forme orale- qté est. 1ère période: 465956/

lot no106: uro dutasteride + tamsulosine- sl no1: 0.5 mg / 0.4 mg Gélules- qté est. 1ère période: 38254/

lot no107: uro oxybutynine forme orale sèche- sL no1: 5 mg- qté est. 1ère période: 801797/

lot no108: uro tamsulosine forme orale sèche- sL no1: 0.4 mg LP- qté est. 1ère période: 1069780/.


Lot 9 à 14

Lot no9: cinacalcet oral- sl no1: 30 mg cp- qté est. 1ère période: 149686/

lot no9: cinacalcet oral- sl no2: 60 mg cp- qté est. 1ère période: 23322/

lot no9: cinacalcet oral- sl no3: 90 mg cp- qté est. 1ère période: 6844/

lot no10: cortivazol injectable- sl no1: 3.75 MG- qté est. 1ère période: 123987/

lot no11: desmopressine formes endonasales- sl no1: sol endonasale- qté est. 1ère période: 450/

lot no11: desmopressine formes endonasales- sl no2: spray nasal- qté est. 1ère période: 1106/

lot no12: desmopressine fort dosage forme nasale- sl no1: 150 mcg spray nasal- qté est. 1ère période: 98/

lot no13: desmopressine injectable- sl no1: 4 MCG- qté est. 1ère période: 51636/

lot no14: desmopressine orale- sl no1: 60 mcg lyo- qté est. 1ère période: 95467/

lot no14: desmopressine orale- sl no2: 120 mcg lyo- qté est. 1ère période: 17323/

lot no14: desmopressine orale- sl no3: 240 mcg lyo- qté est. 1ère période: 2504/.


Lot 109 à 114

Lot no109: uro terazosine- sl no1: 1 mg Comprimés- qté est. 1ère période: 119/

lot no109: uro terazosine- sl no2: 5 mg Comprimés- qté est. 1ère période: 89/

lot no110: URO traitement adénome prostatique par extraits végétaux forme orale- sL no1: extraits végétaux- qté est. 1ère période: 809816/

lot no111: ains acide niflumique Oral- sL no1: oral adulte- qté est. 1ère période: 50120/

lot no112: AINS Diclofénac autres formes- sL no1: diclofénac oral 75mg LP- qté est. 1ère période: 31785/

lot no112: AINS Diclofénac autres formes- sL no2: diclofénac oral 100mg LP- qté est. 1ère période: 65069/

lot no113: AINS Diclofénac voie orale immédiate Faible dosage- sL no1: Diclofénac 25mg oral- qté est. 1ère période: 20476/

lot no114: AINS Diclofénac voie orale immédiate Fort dosage- sL no1: Diclofénac 50 mg Oral- qté est. 1ère période: 116670/.


Lot 115 à 120

Lot no115: AINS Ibuprofène forme séche- sL no1: Ibuprofène 200mg oral — qté est. 1ère période: 4631455/

lot no115: AINS Ibuprofène forme séche- sL no2: Ibuprofène 400mg oral — qté est. 1ère période: 817711/

lot no116: AINS Ibuprofène oral ( pediatrie ) solution buvable- sL no1: Ibuprofène oral solution buvable- qté est. 1ère période: 9711/

lot no117: AINS Indométacine Suppositoire- sL no1: Indométacine Suppositoire- qté est. 1ère période: 9455/

lot no118: AINS Kétoprofène injectable im- sl no1: Kétoprofène 100mg inj IM- qté est. 1ère période: 18914/

lot no119: AINS Kétoprofène injectable iv- sl no1: Kétoprofène 100mg inj IV- qté est. 1ère période: 1233584/

lot no120: AINS Kétoprofène oral 150mg- sL no1: Ketoprofène oral 150mg- qté est. 1ère période: 313/.


Lot 121 à 124

Lot no121: AINS Kétoprofène oral formes immédiates- sL no1: Kétoprofène 50mg oral- qté est. 1ère période: 709247/

lot no121: AINS Kétoprofène oral formes immédiates- sL no2: Kétoprofène 100mg oral- qté est. 1ère période: 939455/

lot no122: ains ketoprofene oral formes retard — sL no1: Kétoprofène 100mg en bi-prise- qté est. 1ère période: 2731707/

lot no122: ains ketoprofene oral formes retard — sL no2: Kétoprofène 200mg oral LP- qté est. 1ère période: 30984/

lot no123: ains morniflumate Suppositoire- sL no1: Suppositoire Enfant- qté est. 1ère période: 26186/

lot no123: ains morniflumate Suppositoire- sL no2: Suppositoire Adulte- qté est. 1ère période: 8042/

lot no124: ains naproxene Oral- sL no1: faible dosage- qté est. 1ère période: 11638/

lot no124: ains naproxene Oral- sL no2: moyen dosage- qté est. 1ère période: 101040/

lot no124: ains naproxene Oral- sL no3: fort dosage- qté est. 1ère période: 896/.


Lot 125 à 127

Lot no125: AINS produit en usage externe (pommade ou gel)- sL no1: tube (application cutanée)- qté est. 1ère période: 171707/

lot no126: ATALUREN — sL no1: 125 mg Granulés pour suspension buvable- qté est. 1ère période: 13535/

lot no126: ATALUREN — sL no2: 250 mg Granulés pour suspension buvable- qté est. 1ère période: 59875/

lot no126: ATALUREN — sL no3: 1000 mg Granulés pour suspension buvable- qté est. 1ère période: 3374/

lot no127: Biphosphonate Acide clodronique oral- sL no1: Acide clodronique fort dosage- qté est. 1ère période: 13578/.


Lot 128 à 131

Lot no128: Biphosphonate Acide pamidronique injectable- sL no1: Acide pamidronique 15mg injectable- qté est. 1ère période: 20429/

lot no128: Biphosphonate Acide pamidronique injectable- sL no2: Acide pamidronique 30mg injectable- qté est. 1ère période: 4153/

lot no128: Biphosphonate Acide pamidronique injectable- sL no3: Acide pamidronique 60mg injectable- qté est. 1ère période: 3243/

lot no128: Biphosphonate Acide pamidronique injectable- sL no4: Acide pamidronique 90mg injectable- qté est. 1ère période: 13737/

lot no129: Biphosphonate Acide zolédronique injectable 4mg- sL no1: injectable- qté est. 1ère période: 22355/

lot no130: Biphosphonate Acide zolédronique injectable 5 mg- sL no1: Acide zolédronique 5 mg injectable- qté est. 1ère période: 4082/

lot no131: Biphosphonate association alendronate 70mg+vit D3 orale 5600u- sL no1: forme orale- qté est. 1ère période: 33665/.


Lot 132 à 134

Lot no132: Biphosphonate forme orale indiquée dans l'ostéoporose post ménopausique- sL no1: dosage hebdomadaire- qté est. 1ère période: 28550/

lot no133: COXIB oral- sL no1: faible dosage- qté est. 1ère période: 16992/

lot no133: COXIB oral- sL no2: fort dosage- qté est. 1ère période: 18341/

lot no134: Curare: Atracurium injectable- sL no1: Atracurium 25mg injectable- qté est. 1ère période: 28079/

lot no134: Curare: Atracurium injectable- sL no2: Atracurium 50mg injectable- qté est. 1ère période: 877301/

lot no134: Curare: Atracurium injectable- sL no3: Atracurium 250mg injectable- qté est. 1ère période: 15290/.


Lot 135 à 138

Lot no135: Curare: Cisatracurium injectable- sL no1: cisatracurium 5mg injectable- qté est. 1ère période: 5382/

lot no135: Curare: Cisatracurium injectable- sL no2: cisatracurium 10mg injectable- qté est. 1ère période: 523636/

lot no135: Curare: Cisatracurium injectable- sL no3: cisatracurium 20mg injectable- qté est. 1ère période: 339572/

lot no135: Curare: Cisatracurium injectable- sL no4: cisatracurium 150 mg injectable- qté est. 1ère période: 211873/

lot no136: Curare: Mivacurium injectable- sL no1: Mivacurium 10mg injectable- qté est. 1ère période: 8035/

lot no136: Curare: Mivacurium injectable- sL no2: Mivacurium 20mg injectable- qté est. 1ère période: 6740/

lot no137: Curare: Rocuronium- sL no1: 50 mg Injectable- qté est. 1ère période: 189092/

lot no138: Curare: Suxaméthonium / succinylcholine 100mg injectable- sL no1: succinylcholine 100mg injectable- qté est. 1ère période: 570780/.


Lot 139 à 144

Lot no139: Décontractant musculaire (baume ou pommade)- sL no1: tube (application cutanée)- qté est. 1ère période: 3812/

lot no140: Inducteur de l'ostéogenese Dibotermine alpha- sL no1: Dibotermine alpha 12mg pour injection- qté est. 1ère période: 1177/

lot no141: Myorelaxant Baclofène injectable- sL no1: Baclofène 0,05mg injectable IT- qté est. 1ère période: 3075/

lot no141: Myorelaxant Baclofène injectable- sL no2: Baclofène 10mg/20ml- qté est. 1ère période: 2355/

lot no141: Myorelaxant Baclofène injectable- sL no3: Baclofène 10mg/5ml- qté est. 1ère période: 28987/

lot no142: Myorelaxant Baclofène injectable Fort dosage- sL no1: 40 mg / 20 ml Injectable- qté est. 1ère période: 96/

lot no143: Myorelaxant Baclofene oral- sL no1: Myorelaxant Baclofene oral 10mg- qté est. 1ère période: 2772822/

lot no144: Myorelaxant Dantrolène injectable- sL no1: Dantrolène 20mg injectable- qté est. 1ère période: 9000/.


Lot 145 à 147

Lot no145: Toxine botulique de type A injectable- sL no1: 50ui flacon injectable- qté est. 1ère période: 12718/

lot no145: Toxine botulique de type A injectable- sL no2: 100ui flacon injectable- qté est. 1ère période: 43276/

lot no145: Toxine botulique de type A injectable- sL no3: 200ui flacon injectable- qté est. 1ère période: 18915/

lot no146: Toxine botulique de type A injectable fort dosage- sL no1: 300ui flacon injectable- qté est. 1ère période: 11079/

lot no146: Toxine botulique de type A injectable fort dosage- sL no2: 500ui flacon injectable- qté est. 1ère période: 31906/

lot no147: Toxine botulique de type A injectable stabilisée- sL no1: 100ui flacon injectable- qté est. 1ère période: 22797/

lot no147: Toxine botulique de type A injectable stabilisée- sL no2: 50ui flacon injectable- qté est. 1ère période: 6602/

lot no147: Toxine botulique de type A injectable stabilisée- sL no3: 200 UI Flacon injectable- qté est. 1ère période: 2850/.


Lot 148 à 150

Lot no148: Toxine botulique de type B Injectable- sL no1: 2 500 UI Flacon injectable- qté est. 1ère période: 88/

lot no148: Toxine botulique de type B Injectable- sL no2: 5 000 UI Flacon injectable- qté est. 1ère période: 100/

lot no148: Toxine botulique de type B Injectable- sL no3: 10 000 UI Flacon injectable- qté est. 1ère période: 125/

lot no149: TT anti-goutteux Allopurinol oral- sL no1: Allopurinol 100mg oral- qté est. 1ère période: 1266386/

lot no149: TT anti-goutteux Allopurinol oral- sL no2: Allopurinol 200mg oral- qté est. 1ère période: 87799/

lot no149: TT anti-goutteux Allopurinol oral- sL no3: Allopurinol 300mg oral- qté est. 1ère période: 136631/

lot no150: TT anti-goutteux Colchicine orale- sL no1: Colchicine 1mg orale- qté est. 1ère période: 470992/.


Lot 15 à 22

Lot no15: dexamethasone injectable- sl no1: 4 MG- qté est. 1ère période: 988058/

lot no15: dexamethasone injectable- sl no2: 20 MG- qté est. 1ère période: 282637/

lot no16: dexamethasone faible dosage- sl no1: 0.5 mg comprimés- qté est. 1ère période: 94386/

lot no17: fludrocortisone orale fort dosage- sl no1: 50 MCG- qté est. 1ère période: 121592/

lot no18: glucagon injectable- sl no1: 1 MG- qté est. 1ère période: 64647/

lot no19: gonadoreline injectable- sl no1: 3.2 MG- qté est. 1ère période: 102/

lot no20: hydrocortisone injectable- sl no1: 100 MG- qté est. 1ère période: 608622/

lot no20: hydrocortisone injectable- sl no2: 500 MG- qté est. 1ère période: 10052/

lot no21: hydrocortisone orale- sl no1: 10 mg cp- qté est. 1ère période: 1017484/

lot no22: KETOCONAZOLE Oral- sL no1: 200 mg comprimés- qté est. 1ère période: 40368/.


Lot 151 à 154

Lot no151: TT anti-goutteux Febuxostat oral- sL no1: Febuxostat 80mg oral- qté est. 1ère période: 149588/

lot no151: TT anti-goutteux Febuxostat oral- sL no2: Febuxostat 120mg oral- qté est. 1ère période: 15278/

lot no152: ABATACEPT Injectable- sL no1: 125 mg Solution injectable- qté est. 1ère période: 257/

lot no152: ABATACEPT Injectable- sL no2: 125 mg Injectable en Stylo pré-rempli- qté est. 1ère période: 224/

lot no152: ABATACEPT Injectable- sL no3: 250 mg Injectable IV- qté est. 1ère période: 58164/

lot no153: ADALIMUMAB Injectable- sL no1: 40 mg / 0.8 ml Solution pédriatique Injectable- qté est. 1ère période: 367/

lot no153: ADALIMUMAB Injectable- sL no2: 40 mg Stylo injectable- qté est. 1ère période: 6197/

lot no153: ADALIMUMAB Injectable- sL no3: 40 mg Seringue pré-remplie- qté est. 1ère période: 3187/

lot no154: ANAKINRA Injectable — sL no1: Anakinra injectable 100mg- qté est. 1ère période: 6050/.


Lot 155 à 160

Lot no155: AZATHIOPRINE Injectable- sL no1: Azathioprine injectable 50mg- qté est. 1ère période: 1762/

lot no156: AZATHIOPRINE Orale 25 mg- sL no1: Azathioprine 25mg oral- qté est. 1ère période: 35214/

lot no157: AZATHIOPRINE Orale 50 mg- sL no1: 50 mg Orale- qté est. 1ère période: 195356/

lot no158: certonizumab- sl no1: Injectable- qté est. 1ère période: 905/

lot no159: DENOSUMAB Injectable Faible dosage- sL no1: DENOSUMAB Injectable Faible dosage 60 mg — 1 ml- qté est. 1ère période: 216/

lot no160: DENOSUMAB Injectable Fort dosage- sL no1: DENOSUMAB Injectable Fort dosage 120 mg — 1,7 ml- qté est. 1ère période: 837/.


Lot 161 à 164

Lot no161: GOLIMUMAB Injectable- sL no1: Stylo injectable 50 mg- qté est. 1ère période: 434/

lot no161: GOLIMUMAB Injectable- sL no2: Stylo injectable 100 mg- qté est. 1ère période: 358/

lot no161: GOLIMUMAB Injectable- sL no3: Seringue pré-remplie 50 mg- qté est. 1ère période: 110/

lot no161: GOLIMUMAB Injectable- sL no4: Seringue pré-remplie 100 mg- qté est. 1ère période: 54/

lot no162: HYDROXYCHLOROQUINE Orale- sL no1: TT de la PR: Hydroxychloroquine orale 200mg- qté est. 1ère période: 159160/

lot no163: IXEKIZUMAB Injectable- sL no1: Injectable- qté est. 1ère période: 83/

lot no164: LEFLUNOMIDE Orale- sL no1: Léflunomide 10mg oral — qté est. 1ère période: 9008/

lot no164: LEFLUNOMIDE Orale- sL no2: Léflunomide 20mg oral- qté est. 1ère période: 16971/

lot no164: LEFLUNOMIDE Orale- sL no3: Léflunomide 100mg oral- qté est. 1ère période: 1163/.


Lot 165 à 167

Lot no165: SECUKINUMAB Injectable- sL no1: Stylo injectable pré-rempli- qté est. 1ère période: 341/

lot no165: SECUKINUMAB Injectable- sL no2: Seringue injectable pré-remplie- qté est. 1ère période: 272/

lot no166: TOCILIZUMAB Injectable- sL no1: Tocilizumab 80mg injectable- qté est. 1ère période: 39399/

lot no166: TOCILIZUMAB Injectable- sL no2: Tocilizumab 200mg injectable- qté est. 1ère période: 17584/

lot no166: TOCILIZUMAB Injectable- sL no3: Tocilizumab 400mg injectable- qté est. 1ère période: 25794/

lot no166: TOCILIZUMAB Injectable- sL no4: Tocilizumab Sous Cutané- qté est. 1ère période: 190/

lot no167: USTEKINUMAB Injectable- sL no1: 45 mg Flacon- qté est. 1ère période: 2561/

lot no167: USTEKINUMAB Injectable- sL no2: 45 mg Seringue pré-remplie- qté est. 1ère période: 1049/

lot no167: USTEKINUMAB Injectable- sL no3: 90 mg Seringue pré-remplie- qté est. 1ère période: 763/.


Lot 168 à 176 (sauf 169)

Lot no168: VEDOLIZUMAB Injectable- sL no1: Injectable- qté est. 1ère période: 18272/

lot no170: Anticorps anti digitaline- sL no1: 40 mg — qté est. 1ère période: 1070/

lot no173: DEFERIPRONE orale- sL no1: 500mg- qté est. 1ère période: 198482/

lot no173: DEFERIPRONE orale- sL no2: 1g- qté est. 1ère période: 129826/

lot no173: DEFERIPRONE orale- sL no3: solution buvable- qté est. 1ère période: 423/

lot no174: DEFERASIROX Oral- sL no1: 125 mg Oral- qté est. 1ère période: 4659/

lot no174: DEFERASIROX Oral- sL no2: 500 mg Oral- qté est. 1ère période: 16941/

lot no175: DEFEROXAMINE Injectable- sL no1: 500mg- qté est. 1ère période: 17071/

lot no176: diazoxide- sl no1: 25mg gélule- qté est. 1ère période: 119873/

lot no176: diazoxide- sl no2: 100mg gélule- qté est. 1ère période: 63695/.


Lot 177 à 185

Lot no177: DIMERCAPROL Injectable- sL no1: inj- qté est. 1ère période: 868/

lot no178: EDETATE dicobaltique- sL no1: amp inj 20ml- qté est. 1ère période: 331/

lot no179: calcium edetate sodium- sl no1: 50mg/ml sol perf iv- qté est. 1ère période: 2919/

lot no180: ETHANOL Injectable- sL no1: 26 % Injectable- qté est. 1ère période: 3485/

lot no181: FLUMAZENIL Injectable- sL no1: 0,5mg injectable- qté est. 1ère période: 71779/

lot no181: FLUMAZENIL Injectable- sL no2: 1mg injectable- qté est. 1ère période: 54621/

lot no182: HYDROXYCOBALAMINE Injectable- sL no1: 5 g Injectable- qté est. 1ère période: 1943/

lot no183: IDARUCIZUMAB Injectable- sL no1: 2.5 mg / 50 ml Injectable- qté est. 1ère période: 644/

lot no184: methylthioninium chlorure Injectable- sL no1: 5 mg / ml Injectable- qté est. 1ère période: 10323/

lot no185: N-ACETYLCYSTEINE fort dosage injectable- sL no1: 5g/25ml INJ- qté est. 1ère période: 72372/.


Lot 186 à 194 (sauf 192)

Lot no186: NALOXONE Injectable- sL no1: 0,4mg INJ- qté est. 1ère période: 115133/

lot no187: PRALIDOXIME Injectable- sL no1: 2 % poudre / solv pr sol inj- qté est. 1ère période: 6842/

lot no188: PROTAMINE injectable- sL no1: inj- qté est. 1ère période: 143549/

lot no189: SUCCIMER Oral — sL no1: 200 mg Forme orale- qté est. 1ère période: 10963/

lot no189: SUCCIMER Oral — sL no2: 100 mg Forme orale- qté est. 1ère période: 393/

lot no190: TOXICARB — sL no1: Flacon 60 ml- qté est. 1ère période: 442/

lot no190: TOXICARB — sL no2: Flacon 250 ml- qté est. 1ère période: 7095/

lot no191: ajmaline- sl no1: 50 mg Injectable — qté est. 1ère période: 3973/

lot no193: carmin indigo- sl no1: 40 mg Injectable- qté est. 1ère période: 49298/

lot no194: corticoreline- sl no1: 0.1 mg / 1 ml Injectable- qté est. 1ère période: 1281/.


Lot 196 à 202 (sauf 200) et 81

Lot no196: gonadoreline- sl no1: 0.10 mg / ml Injectable- qté est. 1ère période: 7664/

lot no197: metyrapone- sl no1: 250 mg Capsule- qté est. 1ère période: 240433/

lot no198: somatoreline- sl no1: 0.05 mg Injectable- qté est. 1ère période: 1793/

lot no199: tuberculine- sl no1: 5 ui / 0.1 ml Injectable- qté est. 1ère période: 219869/

lot no201: dexamethasone fort dosage- sl no1: 40mg comprimés- qté est. 1ère période: 112513/

lot no202: AINS Kétoproféne suppositoire- sL no1: Kétoproféne suppositoire 100mg- qté est. 1ère période: 43107/

lot no81: levonorgestrel + ethinylestradiol pour administration séquentielle biphasique- sL no1: comp- qté est. 1ère période: 80647/.


Lot 169 et 192

Lot no169: belimumab inj- sl no1: 120 mg Solution à diluer- qté est. 1ère période: 3781/

lot no169: belimumab inj- sl no2: 400 mg Solution à diluer- qté est. 1ère période: 1894/

lot no192: bleu patente- sl no1: Injectable- qté est. 1ère période: 30922/.


Lot 195 et 200

Lot no195: fluoresceine- sl no1: 10 % Injectable- qté est. 1ère période: 25489/

lot no195: fluoresceine- sl no2: 0.5 % Collyre- qté est. 1ère période: 552987/

lot no200: VERT D'Indocyanine- sL no1: 25 mg Injectable- qté est. 1ère période: 13121/.


Lot 23 à 25

Lot no23: l thyroxine buvable- sl no1: GOUTTES- qté est. 1ère période: 14101/

lot no24: l thyroxine injectable- sl no1: 0.2 MG- qté est. 1ère période: 35279/

lot no25: l thyroxine orale- sl no1: 25 mcg cp- qté est. 1ère période: 2428861/

lot no25: l thyroxine orale- sl no2: 50 MCG- qté est. 1ère période: 2742882/

lot no25: l thyroxine orale- sl no3: 75 MCG- qté est. 1ère période: 649764/

lot no25: l thyroxine orale- sl no4: 100 MCG- qté est. 1ère période: 1746857/

lot no25: l thyroxine orale- sl no5: 125 MCG- qté est. 1ère période: 71801/

lot no25: l thyroxine orale- sl no6: 150 MCG- qté est. 1ère période: 103475/

lot no25: l thyroxine orale- sl no7: 175 MCG- qté est. 1ère période: 6964/

lot no25: l thyroxine orale- sl no8: 200 MCG- qté est. 1ère période: 2048/.


Lot 26 à 27

Lot no26: lanreotide injectable- sl no1: 30 mg lp- qté est. 1ère période: 2719/

lot no26: lanreotide injectable- sl no2: 60 mg lp- qté est. 1ère période: 533/

lot no26: lanreotide injectable- sl no3: 90 mg lp- qté est. 1ère période: 207/

lot no26: lanreotide injectable- sl no4: 120 mg lp- qté est. 1ère période: 299/

lot no27: methylprednisolone injectable- sl no1: 20 MG- qté est. 1ère période: 748998/

lot no27: methylprednisolone injectable- sl no2: 40 MG- qté est. 1ère période: 1690223/

lot no27: methylprednisolone injectable- sl no3: 120 MG- qté est. 1ère période: 464217/

lot no27: methylprednisolone injectable- sl no4: 500 MG- qté est. 1ère période: 121652/

lot no27: methylprednisolone injectable- sl no5: 1 G- qté est. 1ère période: 30082/.


Lot 28 à 32

Lot no28: methylprednisolone orale- sl no1: 4 MG- qté est. 1ère période: 49581/

lot no28: methylprednisolone orale- sl no2: 16 MG- qté est. 1ère période: 172317/

lot no28: methylprednisolone orale- sl no3: 100 MG- qté est. 1ère période: 82186/

lot no29: methylprednisolone suspension injectable- sl no1: 40 MG- qté est. 1ère période: 129020/

lot no30: octreotide forme retard injectable- sl no1: 10 mg lp- qté est. 1ère période: 126/

lot no30: octreotide forme retard injectable- sl no2: 20 mg lp- qté est. 1ère période: 418/

lot no30: octreotide forme retard injectable- sl no3: 30 mg lp- qté est. 1ère période: 1925/

lot no31: octreotide injectable- sl no1: 50 MCG- qté est. 1ère période: 18256/

lot no31: octreotide injectable- sl no2: 100 MCG- qté est. 1ère période: 274744/

lot no31: octreotide injectable- sl no3: 500 MCG- qté est. 1ère période: 103354/

lot no32: oxytocine injectable- sl no1: 5 UI- qté est. 1ère période: 1176131/.


Lot 33 à 35

Lot no33: PASIREOTIDE Injectable- sL no1: 0.3 mg Injectable- qté est. 1ère période: 40/

lot no33: PASIREOTIDE Injectable- sL no2: 0.6 mg Injectable- qté est. 1ère période: 1035/

lot no33: PASIREOTIDE Injectable- sL no3: 0.9 mg Injectable- qté est. 1ère période: 188/

lot no34: PASIREOTIDE Poudre pour suspension injectable- sL no1: 20 mg Poudre pour suspension injectable- qté est. 1ère période: 23/

lot no34: PASIREOTIDE Poudre pour suspension injectable- sL no2: 40 mg Poudre pour suspension injectable- qté est. 1ère période: 30/

lot no34: PASIREOTIDE Poudre pour suspension injectable- sL no3: 60 mg Poudre pour suspension injectable- qté est. 1ère période: 26/

lot no35: PEGVISOMANT Injectable — sL no1: PEGVISOMANT Injectable 10 mg- qté est. 1ère période: 19/

lot no35: PEGVISOMANT Injectable — sL no2: PEGVISOMANT Injectable 15 mg- qté est. 1ère période: 69/

lot no35: PEGVISOMANT Injectable — sL no3: PEGVISOMANT Injectable 20 mg- qté est. 1ère période: 39/.


Lot 36 à 41

Lot no36: PREDNISOLONE Buvable- sL no1: 1 mg/ml Buvable- qté est. 1ère période: 1873/

lot no37: prednisolone injectable- sl no1: 125 MG- qté est. 1ère période: 21094/

lot no38: prednisolone orale- sl no1: 5 MG- qté est. 1ère période: 710988/

lot no38: prednisolone orale- sl no2: 20 MG- qté est. 1ère période: 3594998/

lot no39: prednisone orale- sl no1: 1 mg cp- qté est. 1ère période: 446958/

lot no39: prednisone orale- sl no2: 5 mg cp- qté est. 1ère période: 1176739/

lot no39: prednisone orale- sl no3: 20 mg cp- qté est. 1ère période: 1487793/

lot no40: propylthiouracile oral- sl no1: 50 mg cp- qté est. 1ère période: 191983/

lot no41: somatostatine injectable- sl no1: 0.25 MG- qté est. 1ère période: 534/

lot no41: somatostatine injectable- sl no2: 3 MG- qté est. 1ère période: 20431/

lot no41: somatostatine injectable- sl no3: 6mg- qté est. 1ère période: 13262/.


Lot 43 à 49

Lot no43: TETRACOSACTIDE Injectable- sL no1: 0.25 mg- qté est. 1ère période: 25152/

lot no43: TETRACOSACTIDE Injectable- sL no2: 1 mg Forme Retard- qté est. 1ère période: 3172/

lot no44: thyrotropine alpha injectable- sl no1: 0.9mg- qté est. 1ère période: 13999/

lot no45: triamcinolone injectable- sl no1: 40 MG- qté est. 1ère période: 16633/

lot no45: triamcinolone injectable- sl no2: 80 MG- qté est. 1ère période: 6522/

lot no46: cyproterone + ethinylestradiol- sl no1: comp- qté est. 1ère période: 2009/

lot no47: CYPROTERONE forme orale sèche- sL no1: 100 mg- qté est. 1ère période: 8016/

lot no47: CYPROTERONE forme orale sèche- sL no2: 50 mg- qté est. 1ère période: 126045/

lot no48: DESOGESTREL — sL no1: 0.075 mg Comprimés- qté est. 1ère période: 168647/

lot no49: diethylstilbestrol- sl no1: 1 mg Comprimés- qté est. 1ère période: 1379/.

Download full details as .pdf
The Buyer:
CHU de Bordeaux
CPV Code(s):
33600000 - Pharmaceutical products